Trial Details
COMPLETEDBasic Information
| Clinical ID | c931 |
|---|---|
| Identifier | NCT03412682 |
| Trial Title | To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Budesonide (6 mg)|DRUG: Budesonide (9 mg)|DRUG: Mesalazine (3,600 mg) |
Participant Information
| Sponsor | Ferring Pharmaceuticals |
|---|---|
| City | Nagoya-shi |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2018-03-02 |
|---|---|
| Primary Completion Date | 2020-05-11 |
| Completion Date | 2020-05-26 |